| UC | CD | ||
---|---|---|---|---|
 | N | % | N | % |
Total | 64 | Â | 64 | Â |
Sex | Â | Â | Â | Â |
   Men | 40 | 62.5 | 35 | 54.7 |
   Women | 24 | 37.5 | 29 | 45.3 |
Age, mean (SD) | 51.2(13.4) | 40.3(15.6) | ||
Age at onset | Â | Â | Â | Â |
   ≥40 yrs | - | 11 | 17.2 | |
   <40 yrs | - | 53 | 82.8 | |
Current smoking | Â | Â | Â | Â |
   No | 54 | 84.4 | 21 | 32.8 |
   Yes | 10 | 15.6 | 43 | 67.2 |
Disease duration, mean (SD), years | 7.1(0.3) | 5.3(0.3) | ||
Disease extent (UC) | Â | Â | Â | Â |
   Proctitis | 18 | 28.1 | - | - |
   Left-sided colitis | 22 | 34.4 | - | - |
   Pancolitis | 24 | 37.5 | - | - |
Disease location (CD) | Â | Â | Â | Â |
   Ileitis | - | - | 22 | 34.4 |
   Colitis | - | - | 11 | 17.2 |
   Ileocolitis | - | - | 31 | 48.4 |
Disease behavior | Â | Â | Â | Â |
   Stricturing | - | - | 14 | 21.9 |
   Penetrating | - | - | 9 | 14.1 |
   NS/NP | - | - | 41 | 64 |
Extraintestinal manifestations | Â | Â | Â | Â |
   None | 43 | 67.2 | 34 | 53.1 |
   1 or more | 21 | 32.8 | 30 | 46.9 |
Treatment | Â | Â | Â | Â |
   5-ASA | 49 | 76.6 | 54 | 84.4 |
   Corticosteroids | 25 | 39.1 | 46 | 71.9 |
   Immunosuppressants | 14 | 21.9 | 21 | 32.8 |
   Anti-TNF | 3 | 4.7 | 16 | 25.0 |
   Surgery | 1 | 1.6 | 2 | 3.1 |